Corbus Pharmaceuticals Holdings Inc (CRBP) USD0.0001

Sell:$9.92Buy:$10.78$0.13 (1.27%)

Prices delayed by at least 15 minutes
Sell:$9.92
Buy:$10.78
Change:$0.13 (1.27%)
Prices delayed by at least 15 minutes
Sell:$9.92
Buy:$10.78
Change:$0.13 (1.27%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 October 2025
Yuval CohenCEO
Sell
Option/Award related
8,973$17.14$153,797.22138,187
24 October 2025
Yuval CohenCEO
Sell
Option/Award related
18,660$17.01$317,406.60138,187
24 October 2025
Sean F MoranCFO
Sell
Option/Award related
12,981$17.02$220,936.6273,313
20 October 2025
Anne AltmeyerDirector
Sell
Option/Award related
1,060$20.50$21,730.006,191
30 May 2025
Anne AltmeyerDirector
Sell
Regular sell transaction (market)
1,392$7.25$10,095.621,391
30 May 2025
John Kenneth JenkinsDirector
Sell
Regular sell transaction (market)
2,783$7.35$20,465.3533
6 March 2025
Dominic SmethurstChief Level Officer
Sell
Tax related
6,393$6.78$43,329.8470,807
14 February 2025
Yuval CohenCEO
Sell
Tax related
7,134$8.76$62,464.59138,187
14 February 2025
Sean F MoranCFO
Sell
Tax related
2,792$8.76$24,446.4773,313

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
24 October 2025
Yuval CohenCEO
Sell
Option/Award related
18,660$17.01$317,406.60138,187
24 October 2025
Sean F MoranCFO
Sell
Option/Award related
12,981$17.02$220,936.6273,313
27 October 2025
Yuval CohenCEO
Sell
Option/Award related
8,973$17.14$153,797.22138,187
14 February 2025
Yuval CohenCEO
Sell
Tax related
7,134$8.76$62,464.59138,187
6 March 2025
Dominic SmethurstChief Level Officer
Sell
Tax related
6,393$6.78$43,329.8470,807

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.